German Cancer Society Neuro‐Oncology Working Group NOA‐03 multicenter trial of single‐agent high‐dose methotrexate for primary central nervous system lymphoma
暂无分享,去创建一个
J. Dichgans | M. Weller | C. Meisner | L. Kanz | O. Wiestler | M. Deckert | W. Brugger | R. Kortmann | M. Bamberg | M. Schabet | U. Herrlinger | W. Küker | H. Mergenthaler | C. Engel | P. Krauseneck | H. Schmeck-Lindenau | C. Benöhr
[1] R. D. Hunter,et al. WHO Handbook for Reporting Results of Cancer Treatment , 1980 .
[2] L. Deangelis,et al. Combined modality therapy for primary CNS lymphoma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] M. Reni,et al. Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] David Fortin,et al. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood‐brain barrier for the treatment of patients with malignant brain tumors , 2000, Cancer.
[5] F. Hochberg,et al. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. , 1994, Journal of neurosurgery.
[6] J. Dichgans,et al. Primary central nervous system lymphoma 1991–1997 , 2001, Cancer.
[7] C. Pollack,et al. Intravenous Methotrexate as Initial Treatment for Primary Central Nervous System Lymphoma: Response to Therapy and Quality of Life of Patients , 1999, Journal of Neuro-Oncology.
[8] J. Blay,et al. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[10] E. Ezdinli,et al. Corticosteroid therapy for lymphomas and chronic lymphocytic leukemia , 1969, Cancer.
[11] L. Deangelis,et al. Treatment for primary CNS lymphoma: the next step. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] L. Deangelis,et al. Long-term survival in primary CNS lymphoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] T. Cascino,et al. Response criteria for phase II studies of supratentorial malignant glioma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] R. Simon,et al. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] D. Nelson,et al. Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. , 1992, International journal of radiation oncology, biology, physics.
[16] High-dose methotrexate for primary CNS lymphoma in the elderly. , 2000, Neuro-oncology.
[17] D. Kraemer,et al. Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma. , 2000, Neurosurgery.
[18] M. Barton,et al. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.